首页> 外文期刊>Retina >RANIBIZUMAB FOR MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION One Initial Injection Versus Three Monthly Injections
【24h】

RANIBIZUMAB FOR MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION One Initial Injection Versus Three Monthly Injections

机译:ranibizumab用于黄斑水肿后分支后视网膜静脉闭塞一首初始注射与三月注射

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To compare the 12-month-efficacy of 1 initial intravitreal ranibizumab injection (IVR) followed by pro re nata (PRN) dosing with that of three initial monthly IVR followed by PRN dosing in patients with macular edema (ME) after branch retinal vein occlusion.
机译:目的:比较1个初始玻璃体植物植物的12个月疗效,然后用三个初始每月IVR给药,随后将PRN给药,在分支视网膜后黄斑水肿(ME)患者中的PRN给药。 静脉闭塞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号